Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-Marketing Surveillance Study on the Safety and Effectiveness of Doripenem Among Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections

NCT01763008 is registered in ClinicalTrials.gov with Janssen Pharmaceutica as lead sponsor.

NCT NCT01763008
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01763008 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-Marketing Surveillance Study on the Safety and Effectiveness of Doripenem Among Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections
Lead sponsor
Janssen Pharmaceutica
Phase
Observational
Overall status
Completed
Start date
November 30, 2009
Completion date
November 30, 2012
Enrollment
170 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

intraabdominal infections, nosocomial infection, pneumonia, bacterial, urinary tract infection